DiscoveryPak™ Receptor Tyrosine Kinase (RTK) Inhibitor Set | K859

A convenient set consisting of eight Receptor Tyrosine Kinase (RTK) inhibitors. The eight inhibitors are: 5 mg of Axitinib (Cat. No. 1581-5), 5 mg of Canertinib (Cat. No. 1617-5), 5 mg of Gefitinib (Cat. No. 1589-5), 5 mg of GW2580 (Cat. No. 1740-5), 25 mg of Lapatinib Ditosylate (Cat. No. 1624-25), 1 mg of PD-173074 (Cat. No. 1675-1), 1 mg of SB-431542 (Cat. No. 1674-1), and 100 mg of Sunitinib Malate (Cat. No. 1611-100).

DiscoveryPak™ Receptor Tyrosine Kinase (RTK) Inhibitor Set is a convenient set consisting of eight Receptor Tyrosine Kinase (RTK) inhibitors. The eight inhibitors are: 5 mg of Axitinib (Cat. No. 1581-5), 5 mg of Canertinib (Cat. No. 1617-5), 5 mg of Gefitinib (Cat. No. 1589-5), 5 mg of GW2580 (Cat. No. 1740-5), 25 mg of Lapatinib Ditosylate (Cat. No. 1624-25), 1 mg of PD-173074 (Cat. No. 1675-1), 1 mg of SB-431542 (Cat. No. 1674-1), and 100 mg of Sunitinib Malate (Cat. No. 1611-100).

K859 | DiscoveryPak™ Receptor Tyrosine Kinase (RTK) Inhibitor Set DataSheet

Alternate Name/Synonyms: Receptor Tyrosine Kinase (RTK) Inhibitor Set, DiscoveryPak™

Appearance: Lyophilized solids

Formulation: N/A

CAS Number: See under the individual product

Structure Available?: See under the individual product

Peptide sequence: N/A

Salt Form: No

Molecular Formula: See under the individual product

Molecular Weight: See under the individual product

Cell-Permeable?: Yes

Purity: ≥95% by HPLC

Solubilities: DMSO

Handling: Protect from air, light and moisture

Country of Origin: USA

Tag Line: A Receptor Tyrosine Kinase (RTK) inhibitors panel

MDL Number: N/A

PubChem CID: N/A

SMILES: N/A

InChi: N/A

InChi Key: N/A